Clinical Trial

Assessment of Blood Indices in Systemic Lupus Erythematosus

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This case-control study aims to explore the relationship between specific blood indices (lymphocyte-monocyte ratio, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and systemic immune-inflammatory index) and disease activity in patients with systemic lupus erythematosus (SLE). The study includes 70 SLE patients and 70 healthy controls, matched for age and gender, recruited from Assiut University Hospital. Disease activity is assessed using the SLEDAI-2K score, and blood indices are analyzed to determine correlations with disease activity.
Trial Details
NCT Number NCT06872086
Lead Sponsor Assiut University
Conditions SLE, Blood Indices
Enrollment 70 participants
Start Date 2025-05-01
Primary Completion 2026-08-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-03-12